Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction
SEC Form 4 Filing
Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting and subsequent disposal of restricted stock units on June 15, 2024.
Summary
- On June 15, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., had 42,202 restricted stock units (RSUs) vest.
- Upon vesting, these RSUs were converted into Class A Common Stock and then disposed of.
- The transaction resulted in Singleton owning 76,867 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into insider activity.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and stock ownership.
- The vesting of RSUs is part of the executive's compensation package.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date of transaction: vesting of restricted stock units and disposal of shares. |
| 06/18/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.